602 related articles for article (PubMed ID: 15486318)
1. Plasma cholesteryl esters provided by lecithin:cholesterol acyltransferase and acyl-coenzyme a:cholesterol acyltransferase 2 have opposite atherosclerotic potential.
Lee RG; Kelley KL; Sawyer JK; Farese RV; Parks JS; Rudel LL
Circ Res; 2004 Nov; 95(10):998-1004. PubMed ID: 15486318
[TBL] [Abstract][Full Text] [Related]
2. Dietary fat-induced alterations in atherosclerosis are abolished by ACAT2-deficiency in ApoB100 only, LDLr-/- mice.
Bell TA; Kelley K; Wilson MD; Sawyer JK; Rudel LL
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1396-402. PubMed ID: 17431188
[TBL] [Abstract][Full Text] [Related]
3. Lecithin:cholesterol acyltransferase deficiency increases atherosclerosis in the low density lipoprotein receptor and apolipoprotein E knockout mice.
Furbee JW; Sawyer JK; Parks JS
J Biol Chem; 2002 Feb; 277(5):3511-9. PubMed ID: 11719520
[TBL] [Abstract][Full Text] [Related]
4. Deficiency of acyl CoA:cholesterol acyltransferase 2 prevents atherosclerosis in apolipoprotein E-deficient mice.
Willner EL; Tow B; Buhman KK; Wilson M; Sanan DA; Rudel LL; Farese RV
Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1262-7. PubMed ID: 12538880
[TBL] [Abstract][Full Text] [Related]
5. ACAT2 contributes cholesteryl esters to newly secreted VLDL, whereas LCAT adds cholesteryl ester to LDL in mice.
Lee RG; Shah R; Sawyer JK; Hamilton RL; Parks JS; Rudel LL
J Lipid Res; 2005 Jun; 46(6):1205-12. PubMed ID: 15805543
[TBL] [Abstract][Full Text] [Related]
6. In vivo contribution of LCAT to apolipoprotein B lipoprotein cholesteryl esters in LDL receptor and apolipoprotein E knockout mice.
Furbee JW; Francone O; Parks JS
J Lipid Res; 2002 Mar; 43(3):428-37. PubMed ID: 11893779
[TBL] [Abstract][Full Text] [Related]
7. Liver-specific inhibition of acyl-coenzyme a:cholesterol acyltransferase 2 with antisense oligonucleotides limits atherosclerosis development in apolipoprotein B100-only low-density lipoprotein receptor-/- mice.
Bell TA; Brown JM; Graham MJ; Lemonidis KM; Crooke RM; Rudel LL
Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1814-20. PubMed ID: 16675724
[TBL] [Abstract][Full Text] [Related]
8. LCAT modulates atherogenic plasma lipoproteins and the extent of atherosclerosis only in the presence of normal LDL receptors in transgenic rabbits.
Brousseau ME; Kauffman RD; Herderick EE; Demosky SJ; Evans W; Marcovina S; Santamarina-Fojo S; Brewer HB; Hoeg JM
Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):450-8. PubMed ID: 10669643
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol esters (CE) derived from hepatic sterol O-acyltransferase 2 (SOAT2) are associated with more atherosclerosis than CE from intestinal SOAT2.
Zhang J; Sawyer JK; Marshall SM; Kelley KL; Davis MA; Wilson MD; Brown JM; Rudel LL
Circ Res; 2014 Oct; 115(10):826-33. PubMed ID: 25239141
[TBL] [Abstract][Full Text] [Related]
10. Transgenic overexpression of human lecithin: cholesterol acyltransferase (LCAT) in mice does not increase aortic cholesterol deposition.
Furbee JW; Parks JS
Atherosclerosis; 2002 Nov; 165(1):89-100. PubMed ID: 12208474
[TBL] [Abstract][Full Text] [Related]
11. Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice.
Föger B; Chase M; Amar MJ; Vaisman BL; Shamburek RD; Paigen B; Fruchart-Najib J; Paiz JA; Koch CA; Hoyt RF; Brewer HB; Santamarina-Fojo S
J Biol Chem; 1999 Dec; 274(52):36912-20. PubMed ID: 10601244
[TBL] [Abstract][Full Text] [Related]
12. Coordinated alteration of hepatic gene expression in fatty acid and triglyceride synthesis in LCAT-null mice is associated with altered PUFA metabolism.
Song H; Zhu L; Picardo CM; Maguire G; Leung V; Connelly PW; Ng DS
Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E17-E25. PubMed ID: 16105858
[TBL] [Abstract][Full Text] [Related]
13. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of acyl-coenzyme A:cholesterol acyltransferase 2 (ACAT2) prevents dietary cholesterol-associated steatosis by enhancing hepatic triglyceride mobilization.
Alger HM; Brown JM; Sawyer JK; Kelley KL; Shah R; Wilson MD; Willingham MC; Rudel LL
J Biol Chem; 2010 May; 285(19):14267-74. PubMed ID: 20231283
[TBL] [Abstract][Full Text] [Related]
15. Plasma FA composition in familial LCAT deficiency indicates SOAT2-derived cholesteryl ester formation in humans.
Pavanello C; Ossoli A; Strazzella A; Risè P; Veglia F; Lhomme M; Parini P; Calabresi L
J Lipid Res; 2022 Jul; 63(7):100232. PubMed ID: 35598637
[TBL] [Abstract][Full Text] [Related]
16. Defining the atherogenicity of large and small lipoproteins containing apolipoprotein B100.
Véniant MM; Sullivan MA; Kim SK; Ambroziak P; Chu A; Wilson MD; Hellerstein MK; Rudel LL; Walzem RL; Young SG
J Clin Invest; 2000 Dec; 106(12):1501-10. PubMed ID: 11120757
[TBL] [Abstract][Full Text] [Related]
17. Mice overexpressing human lecithin: cholesterol acyltransferase are not protected against diet-induced atherosclerosis.
Mehlum A; Muri M; Hagve TA; Solberg LA; Prydz H
APMIS; 1997 Nov; 105(11):861-8. PubMed ID: 9393557
[TBL] [Abstract][Full Text] [Related]
18. Moderate consumption of beer reduces liver triglycerides and aortic cholesterol deposit in LDLr-/- apoB100/100 mice.
Degrace P; Moindrot B; Mohamed I; Gresti J; Clouet P
Atherosclerosis; 2006 Dec; 189(2):328-35. PubMed ID: 16487531
[TBL] [Abstract][Full Text] [Related]
19. Analysis of glomerulosclerosis and atherosclerosis in lecithin cholesterol acyltransferase-deficient mice.
Lambert G; Sakai N; Vaisman BL; Neufeld EB; Marteyn B; Chan CC; Paigen B; Lupia E; Thomas A; Striker LJ; Blanchette-Mackie J; Csako G; Brady JN; Costello R; Striker GE; Remaley AT; Brewer HB; Santamarina-Fojo S
J Biol Chem; 2001 May; 276(18):15090-8. PubMed ID: 11278414
[TBL] [Abstract][Full Text] [Related]
20. Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase 1.
Accad M; Smith SJ; Newland DL; Sanan DA; King LE; Linton MF; Fazio S; Farese RV
J Clin Invest; 2000 Mar; 105(6):711-9. PubMed ID: 10727439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
